Skip to main content

Publisher: Wiley-Blackwell on behalf of the International Society on Thrombosis and Haemostasis

Volume 4, Number 11, November 2006

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Free Content Nucleotide receptor signaling in platelets
pp. 2317-2326(10)
Authors: KAHNER, B. N.; SHANKAR, H.; MURUGAPPAN, S.; PRASAD, G. L.; KUNAPULI, S. P.

Favourites:
ADD

Free Content Is protein C inhibitor antithrombotic and protective in pulmonary hypertension?
pp. 2327-2330(4)
Authors: BEAULIEU, L. M.; CHURCH, F. C.

Favourites:
ADD

Free Content Protective role of protein C inhibitor in monocrotaline-induced pulmonary hypertension
pp. 2331-2339(9)
Authors: NISHII, Y.; GABAZZA, E.C.; FUJIMOTO, H.; NAKAHARA, H.; TAKAGI, T.; BRUNO, N.; D'ALESSANDRO-GABAZZA, C. N.; MARUYAMA, J.; MARUYAMA, K.; HAYASHI, T.; ADACHI, Y.; SUZUKI, K.; TAGUCHI, O.

Favourites:
ADD
Favourites:
ADD

Free Content Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis
pp. 2343-2351(9)
Authors: VAN VEEN, S. Q.; CHEUNG, C. W.; MEIJERS, J. C. M.; VAN GULIK, T. M.; BOERMEESTER, M. A.

Favourites:
ADD
Favourites:
ADD

Free Content Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura
pp. 2355-2364(10)
Authors: LUKEN, B. M.; KAIJEN, P. H. P.; TURENHOUT, E. A. M.; KREMER HOVINGA, J. A.; VAN MOURIK, J. A.; FIJNHEER, R.; VOORBERG, J.

Favourites:
ADD
Favourites:
ADD

Free Content Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome
pp. 2367-2372(6)
Authors: NIETO, J. A.; BRUSCAS, M. J.; RUIZ-RIBO, D.; TRUJILLO-SANTOS, J.; VALLE, R.; RUIZ-GIMENEZ, N.; MONREAL, M.

Favourites:
ADD

Free Content Use of preventive measures for air travel-related venous thrombosis in professionals who attend medical conferences
pp. 2373-2376(4)
Authors: KUIPERS, S.; CANNEGIETER, S. C.; MIDDELDORP, S.; ROSENDAAL, F. R.; BÜLLER, H. R.

Favourites:
ADD

Free Content Prevalence of immune thrombocytopenia: analyses of administrative data
pp. 2377-2383(7)
Authors: SEGAL, J. B.; POWE, N. R.

Favourites:
ADD

Free Content Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open-label study
pp. 2384-2390(7)
Authors: RASMUSSEN, M. S.; JORGENSEN, L. N.; WILLE-JØRGENSEN, P.; NIELSEN, J. D.; HORN, A.; MOHN, A. C.; SØMOD, L.; OLSEN, B.

Favourites:
ADD

Free Content Tissue factor serum levels and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study
pp. 2391-2396(6)
Authors: KELLER, T. T.; NAGEL, C.; TE VELTHUIS, H.; GERDES, V. E. A.; WAREHAM, N. J.; BINGHAM, S. A.; LUBEN, R.; HACK, C. E.; REITSMA, P. H.; LEVI, M.; KHAW, K. T.; BOEKHOLDT, S. M.

Favourites:
ADD

Free Content Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy
pp. 2397-2404(8)
Authors: UNDAS, A.; BRUMMEL-ZIEDINS, K. E.; POTACZEK, D. P.; STOBIERSKA-DZIERZEK, B.; BRYNIARSKI, L.; SZCZEKLIK, A.; MANN, K. G.

Favourites:
ADD

Free Content Peptidomimetic inhibitors for activated protein C: implications for hemophilia management
pp. 2411-2416(6)
Authors: BUTENAS, S.; ORFEO, T.; KALAFATIS, M.; MANN, K. G.

Favourites:
ADD

Free Content Low protein Z levels and risk of occurrence of deep vein thrombosis
pp. 2417-2422(6)
Authors: SANTACROCE, R.; SARNO, M.; CAPPUCCI, F.; SESSA, F.; COLAIZZO, D.; BRANCACCIO, V.; GRANDONE, E.; MARGAGLIONE, M.

Favourites:
ADD

Free Content Platelet nitric oxide synthase is activated by tyrosine dephosphorylation: possible role for SHP-1 phosphatase
pp. 2423-2432(10)
Authors: PATEL, B.; SHARIFI, M.; MILWARD, A. D.; OBERPRIELER, N. G.; GIBBINS, J. M.; PARKIN, S.; NASEEM, K. M.

Favourites:
ADD

Free Content Characterization of a patient with glycoprotein (GP) VI deficiency possessing neither anti-GPVI autoantibody nor genetic aberration
pp. 2433-2442(10)
Authors: KOJIMA, H.; MOROI, M.; JUNG, S. M.; GOTO, S.; TAMURA, N.; KOZUMA, Y.; SUZUKAWA, K.; NAGASAWA, T.

Favourites:
ADD

Free Content Heparanase induces tissue factor expression in vascular endothelial and cancer cells
pp. 2443-2451(9)
Authors: NADIR, Y.; BRENNER, B.; ZETSER, A.; ILAN, N.; SHAFAT, I.; ZCHARIA, E.; GOLDSHMIDT, O.; VLODAVSKY, I.

Favourites:
ADD

Free Content Histamine differentially interacts with tumor necrosis factor-α and thrombin in endothelial tissue factor induction: the role of c-Jun NH2-terminal kinase
pp. 2452-2460(9)
Authors: STEFFEL, J.; ARNET, C.; AKHMEDOV, A.; ISELI, S. M.; LÜSCHER, T. F.; TANNER, F. C.

Favourites:
ADD

Free Content Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome
pp. 2461-2469(9)
Authors: CUADRADO, M. J.; BUENDÍA, P.; VELASCO, F.; AGUIRRE, M. A.; BARBARROJA, N.; TORRES, L. A.; KHAMASHTA, M.; LÓPEZ-PEDRERA, C.

Favourites:
ADD

Free Content Characterization of rat thrombin-activatable fibrinolysis inhibitor (TAFI) – a comparative study assessing the biological equivalence of rat, murine and human TAFI
pp. 2470-2477(8)
Authors: HILLMAYER, K.; MACOVEI, A.; PAUWELS, D.; COMPERNOLLE, G.; DECLERCK, P. J.; GILS, A.

Favourites:
ADD

Free Content Circadian clock molecules CLOCK and CRYs modulate fibrinolytic activity by regulating the PAI-1 gene expression
pp. 2478-2485(8)
Authors: OHKURA, N.; OISHI, K.; FUKUSHIMA, N.; KASAMATSU, M.; ATSUMI, G-I; ISHIDA, N.; HORIE, S.; MATSUDA, J.

Favourites:
ADD

Free Content Flow-based assays for global assessment of hemostasis. Part 1: biorheologic considerations
pp. 2486-2487(2)
Authors: ZWAGINGA, J. J.; NASH, G.; KING, M. R.; HEEMSKERK, J. W. M.; FROJMOVIC, M.; HOYLAERTS, M. F.; SAKARIASSEN, K. S.

Favourites:
ADD

Free Content Effect of protein C and activated protein C on alveolar fibrin deposition and turnover in a piglet model of septic shock
pp. 2488-2490(3)
Authors: VELDMAN, A.; FISCHER, D.; NOLD, M.; SCHRANZ, D.; BLOCH MÜNSTER, A.-M.

Favourites:
ADD

Free Content Reduced von Willebrand factor-cleaving protease (ADAMTS13) activity in acute myocardial infarction
pp. 2490-2493(4)
Authors: KAIKITA, K.; SOEJIMA, K.; MATSUKAWA, M.; NAKAGAKI, T.; OGAWA, H.

Favourites:
ADD

Free Content Postpartum residual venous obstruction of the lower limbs in the matched case–control ‘NOHA first’ study on miscarriage
pp. 2493-2495(3)
Authors: KHAU VAN KIEN, A.; LISSALDE-LAVIGNE, G.; DAUZAT, M.; QUÉRÉ, I.; GRIS, J.-C.

Favourites:
ADD

Free Content Platelet activation in subjects carrying factor V Leiden or factor II A20210 mutations
pp. 2496-2498(3)
Authors: GRANDONE, E.; MARTINELLI, I.; MARGAGLIONE, M.; DRAGANI, A.; DAVÌ, G.

Favourites:
ADD
Favourites:
ADD

Free Content Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
pp. 2508-2509(2)
Authors: GILARD, M.; ARNAUD, B.; LE GAL, G.; ABGRALL, J. F.; BOSCHAT, J.

Favourites:
ADD

Free Content Endotoxemia enhances circulating endothelial cells in humans
pp. 2509-2511(3)
Authors: BOOS, C. J.; MAYR, F. B.; LIP, G. Y. H.; JILMA, B.

Favourites:
ADD

Free Content The von Willebrand disease prophylaxis network: exploring a treatment concept
pp. 2511-2512(2)
Authors: BERNTORP, E.; ABSHIRE, T.

Favourites:
ADD

Free Content Endogenous tissue-type plasminogen activator and cardioembolic brain infarct subtype
pp. 2513-2514(2)
Authors: OLIVOT, J. M.; LABREUCHE, J.; MAHAGNE, M. H.; AIACH, M.; AMARENCO, P.

Favourites:
ADD

Free Content Between-batch variation of calibrator activity can significantly influence fluorogenic measurement of thrombin generation
pp. 2514-2516(3)
Authors: VAN VEEN, J. J.; GATT, A.; COOPER, P. C.; KITCHEN, S.; MAKRIS, M.

Favourites:
ADD

Free Content CORRIGENDUM
pp. 2519-2519(1)

Favourites:
ADD

Free Content ANNOUNCEMENTS
pp. 2520-2520(1)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more